Medical Firm to Build $600M Pharmaceutical Manufacturing Site in North Carolina

Medical equipment maker Steris said it will invest $600 million to build a manufacturing and distribution hub in North Carolina for chemicals used by healthcare and pharmaceutical customers.

The company plans to move its existing chemicals operations from St. Louis, Missouri and Plymouth, Minnesota to the new facility after the project is completed.

• The new 600,000-square-foot facility will be built near North Carolina’s Raleigh-Durham Research Triangle region and produce chemicals used in infection prevention and contamination control.
• Steris expects the site to become operational in two to three years, with distribution activities set to kick off before manufacturing operations.
• CEO Dan Carestio said the investment would help Steris speed up innovation, expand capacity and streamline its U.S. manufacturing and distribution network.
• The new campus is expected to create about 335 jobs across manufacturing, research and development and distribution, according to Steris.
• The company said it selected North Carolina after evaluating several locations, citing access to technical talent and skills in the region.
• State and local economic development programs in North Carolina, Lee County and the city of Sanford are supporting the investment, it added.
• Steris in May forecast fiscal 2027 profit above Wall Street expectations, betting on strong demand for its sterilization services despite narrowly missing estimates for fourth-quarter adjusted profit.

(Reporting by Sahil Pandey in Bengaluru; Editing by Jonathan Ananda)